Absci (NASDAQ:ABSI – Get Rating) is one of 40 public companies in the “Commercial physical research” industry, but how does it contrast to its rivals? We will compare Absci to similar companies based on the strength of its analyst recommendations, valuation, institutional ownership, profitability, earnings, risk and dividends. Profitability This table compares Absci and its […]
Absci (NASDAQ:ABSI – Get Rating) is one of 40 publicly-traded companies in the “Commercial physical research” industry, but how does it weigh in compared to its peers? We will compare Absci to similar companies based on the strength of its valuation, earnings, risk, dividends, analyst recommendations, institutional ownership and profitability. Earnings and Valuation This table […]
Absci (NASDAQ:ABSI – Get Rating) is one of 40 public companies in the “Commercial physical research” industry, but how does it compare to its rivals? We will compare Absci to related businesses based on the strength of its institutional ownership, risk, earnings, analyst recommendations, valuation, profitability and dividends. Profitability This table compares Absci and its […]
Absci (NASDAQ:ABSI – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Monday, Zacks.com reports. According to Zacks, “Absci Corporation is the AI-powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. The company’s Creation(TM) Platform involved in […]
Absci (NASDAQ:ABSI – Get Rating) is one of 40 publicly-traded companies in the “Commercial physical research” industry, but how does it weigh in compared to its peers? We will compare Absci to similar businesses based on the strength of its institutional ownership, profitability, risk, earnings, analyst recommendations, valuation and dividends. Insider and Institutional Ownership 40.0% […]